TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Trial of Micronutrients and Adverse Pregnancy Outcomes
Brief Summary: The purpose of this study is to examine the efficacy of multivitamin supplementation on fetal loss, low birth weight and severe preterm birth in healthy (HIV negative) women.


Options:
A: Arm Label: Vitamin B12; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin B12 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin B12; Assigned to Arm(s): Vitamin B12 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Receiving treatment; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: vitamin b12 | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: vitamin b12; Assigned to Arm(s): Receiving treatment
C: Arm Label: Multivitamins; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Multivitamins-vitamins B-complex, C, and E | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamins-vitamins B-complex, C, and E; Assigned to Arm(s): Multivitamins | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Multivitamins; Type: EXPERIMENTAL; Interventions: Drug: Multivitamins | Arm Label: Multivitamins + Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc, Drug: Multivitamins | Arm Label: Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Zinc; Assigned to Arm(s): Multivitamins + Zinc, Zinc | Intervention Type: DRUG; Name: Multivitamins; Assigned to Arm(s): Multivitamins, Multivitamins + Zinc | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Trial of Micronutrients and Adverse Pregnancy Outcomes
Brief Summary: The purpose of this study is to examine the efficacy of multivitamin supplementation on fetal loss, low birth weight and severe preterm birth in healthy (HIV negative) women.


Options:
A: Intervention Type: DRUG; Name: Nutritional supplements; Assigned to Arm(s): N/A
B: Arm Label: Multivitamins; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Multivitamins-vitamins B-complex, C, and E | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamins-vitamins B-complex, C, and E; Assigned to Arm(s): Multivitamins | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: micronutrient antioxidant; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: micronutrient antioxidant | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Control | Intervention Type: DIETARY_SUPPLEMENT; Name: micronutrient antioxidant; Assigned to Arm(s): micronutrient antioxidant | Intervention Type: DIETARY_SUPPLEMENT; Name: Control; Assigned to Arm(s): Control
D: Arm Label: 400 micrograms of folic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Folic acid: 4 mg versus 0.4 mg per day | Arm Label: 4mg of folic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Folic acid: 4 mg versus 0.4 mg per day | Intervention Type: DRUG; Name: Folic acid: 4 mg versus 0.4 mg per day; Assigned to Arm(s): 400 micrograms of folic acid, 4mg of folic acid

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Trial of Micronutrients and Adverse Pregnancy Outcomes
Brief Summary: The purpose of this study is to examine the efficacy of multivitamin supplementation on fetal loss, low birth weight and severe preterm birth in healthy (HIV negative) women.


Options:
A: Arm Label: Multivitamins; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Multivitamins-vitamins B-complex, C, and E | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamins-vitamins B-complex, C, and E; Assigned to Arm(s): Multivitamins | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: Zinc; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Zinc and vitamin A single dose at enrollment | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo and vitamin A single dose at enrollment | Intervention Type: DRUG; Name: Zinc and vitamin A single dose at enrollment; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo and vitamin A single dose at enrollment; Assigned to Arm(s): 2
D: Arm Label: Daily preventive Zn; placebo treatment; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Daily preventive Zn; placebo treatment | Arm Label: Therapeutic Zn; daily placebo; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Therapeutic Zn; daily placebo | Arm Label: Intermittent Zn; placebo treatment; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Intermittent Zn; placebo treatment | Arm Label: Surveillance control group; Type: ACTIVE_COMPARATOR; Interventions: Other: Surveillance control group | Arm Label: Non-intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DIETARY_SUPPLEMENT; Name: Daily preventive Zn; placebo treatment; Assigned to Arm(s): Daily preventive Zn; placebo treatment | Intervention Type: DIETARY_SUPPLEMENT; Name: Therapeutic Zn; daily placebo; Assigned to Arm(s): Therapeutic Zn; daily placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Intermittent Zn; placebo treatment; Assigned to Arm(s): Intermittent Zn; placebo treatment | Intervention Type: OTHER; Name: Surveillance control group; Assigned to Arm(s): Surveillance control group

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Milk-Borne Transmission of HIV-1C in Botswana ("Mashi")
Brief Summary: The purpose of this study is to find the most effective and safe treatment to prevent the passage of HIV from an infected mother to her baby.


Options:
A: Intervention Type: DRUG; Name: Trizivir; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: atazanavir; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Combivir; Assigned to Arm(s): N/A
B: Arm Label: Trizivir (TZV) Arm; Type: EXPERIMENTAL; Interventions: Drug: Trizivir | Arm Label: Kaletra Arm; Type: EXPERIMENTAL; Interventions: Drug: Lamivudine/Zidovudine, Drug: Lopinavir/Ritonavir | Arm Label: Nevirapine (NVP) Arm; Type: EXPERIMENTAL; Interventions: Drug: Nevirapine | Intervention Type: DRUG; Name: Trizivir; Assigned to Arm(s): Trizivir (TZV) Arm | Intervention Type: DRUG; Name: Lamivudine/Zidovudine; Assigned to Arm(s): Kaletra Arm | Intervention Type: DRUG; Name: Lopinavir/Ritonavir; Assigned to Arm(s): Kaletra Arm | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): Nevirapine (NVP) Arm
C: Intervention Type: DRUG; Name: Abacavir; Assigned to Arm(s): N/A
D: Arm Label: maternal nevirapine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nevirapine | Arm Label: maternal placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: No intervention | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): maternal nevirapine | Intervention Type: DRUG; Name: No intervention; Assigned to Arm(s): maternal placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Milk-Borne Transmission of HIV-1C in Botswana ("Mashi")
Brief Summary: The purpose of this study is to find the most effective and safe treatment to prevent the passage of HIV from an infected mother to her baby.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Nevirapine | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Nevirapine placebo | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Nevirapine placebo; Assigned to Arm(s): 2
B: Arm Label: maternal nevirapine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nevirapine | Arm Label: maternal placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: No intervention | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): maternal nevirapine | Intervention Type: DRUG; Name: No intervention; Assigned to Arm(s): maternal placebo
C: Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Combined short-course zidovudine/nevirapine | Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: HAART | Intervention Type: DRUG; Name: Combined short-course zidovudine/nevirapine; Assigned to Arm(s): B | Intervention Type: DRUG; Name: HAART; Assigned to Arm(s): A
D: Arm Label: Trizivir (TZV) Arm; Type: EXPERIMENTAL; Interventions: Drug: Trizivir | Arm Label: Kaletra Arm; Type: EXPERIMENTAL; Interventions: Drug: Lamivudine/Zidovudine, Drug: Lopinavir/Ritonavir | Arm Label: Nevirapine (NVP) Arm; Type: EXPERIMENTAL; Interventions: Drug: Nevirapine | Intervention Type: DRUG; Name: Trizivir; Assigned to Arm(s): Trizivir (TZV) Arm | Intervention Type: DRUG; Name: Lamivudine/Zidovudine; Assigned to Arm(s): Kaletra Arm | Intervention Type: DRUG; Name: Lopinavir/Ritonavir; Assigned to Arm(s): Kaletra Arm | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): Nevirapine (NVP) Arm

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Milk-Borne Transmission of HIV-1C in Botswana ("Mashi")
Brief Summary: The purpose of this study is to find the most effective and safe treatment to prevent the passage of HIV from an infected mother to her baby.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nevirapine, Drug: AZT, Drug: NVP and AZT | Arm Label: C; Type: EXPERIMENTAL; Interventions: Drug: Nevirapine, Drug: AZT, Drug: NVP+AZT | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: Nevirapine, Drug: NVP | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): A, B, C | Intervention Type: DRUG; Name: AZT; Assigned to Arm(s): A, C | Intervention Type: DRUG; Name: NVP and AZT; Assigned to Arm(s): A | Intervention Type: DRUG; Name: NVP; Assigned to Arm(s): B | Intervention Type: DRUG; Name: NVP+AZT; Assigned to Arm(s): C
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nevirapine | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Nevirapine | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Nevirapine, Drug: HIV immune globulin solution | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): 1, 2, 3 | Intervention Type: DRUG; Name: HIV immune globulin solution; Assigned to Arm(s): 3
C: Arm Label: Abrupt Weaning; Type: EXPERIMENTAL; Interventions: Other: abrupt weaning at 4 months | Arm Label: Exclusive breastfeeding per WHO guidelines; Type: ACTIVE_COMPARATOR; Interventions: Other: Continued exclusive breastfeeding | Intervention Type: OTHER; Name: abrupt weaning at 4 months; Assigned to Arm(s): Abrupt Weaning | Intervention Type: OTHER; Name: Continued exclusive breastfeeding; Assigned to Arm(s): Exclusive breastfeeding per WHO guidelines
D: Arm Label: maternal nevirapine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nevirapine | Arm Label: maternal placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: No intervention | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): maternal nevirapine | Intervention Type: DRUG; Name: No intervention; Assigned to Arm(s): maternal placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison of Two Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive Women From Tanzania
Brief Summary: The purpose of this study is to examine effects of daily administration of multivitamin supplements at doses resembling the Recommended Dietary Allowance (RDA) during pregnancy to HIV positive women decreases the risks of low birth weight (\<2500 g), and pre-term birth (\< 37 weeks gestation), compared to multivitamin supplements at doses above the RDA.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin A or Beta-Carotene Supplements | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin A or Beta-Carotene Supplements | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Vitamin A or Beta-Carotene Supplements | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A or Beta-Carotene Supplements; Assigned to Arm(s): 1, 2, 3
B: Arm Label: MMN; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Multiple micronutrient supplements (MMN) | Arm Label: IFA; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: IFA | Intervention Type: DIETARY_SUPPLEMENT; Name: Multiple micronutrient supplements (MMN); Assigned to Arm(s): MMN | Intervention Type: DIETARY_SUPPLEMENT; Name: IFA; Assigned to Arm(s): IFA
C: Arm Label: Vitamin A; Type: N/A; Interventions: Dietary Supplement: Vitamin A alone | Arm Label: No Vitamin A; Type: N/A; Interventions: Dietary Supplement: Multivitamins excluding vitamin A, Dietary Supplement: multivitamins including vitamin A, Other: Placebo | Arm Label: Multivitamins; Type: N/A; Interventions: Dietary Supplement: Vitamin A alone, Dietary Supplement: Multivitamins excluding vitamin A, Dietary Supplement: multivitamins including vitamin A | Arm Label: No Multivitamins; Type: N/A; Interventions: Dietary Supplement: Vitamin A alone, Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin A alone; Assigned to Arm(s): Multivitamins, No Multivitamins, Vitamin A | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamins excluding vitamin A; Assigned to Arm(s): Multivitamins, No Vitamin A | Intervention Type: DIETARY_SUPPLEMENT; Name: multivitamins including vitamin A; Assigned to Arm(s): Multivitamins, No Vitamin A | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): No Multivitamins, No Vitamin A
D: Arm Label: Multivitamins-Single RDA; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Multivitamins-Single RDA | Arm Label: Multivitamins-Multiples of RDA; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Multivitamins-Multiples of RDA | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamins-Multiples of RDA; Assigned to Arm(s): Multivitamins-Multiples of RDA | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamins-Single RDA; Assigned to Arm(s): Multivitamins-Single RDA

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nutrition, Immunology and Epidemiology of Tuberculosis
Brief Summary: The purpose of this study is to determine the efficacy of micronutrient supplementation among patients with active tuberculosis, half of who are co-infected with HIV-1


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Vitamin D 4000 IU; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin D | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): Vitamin D 4000 IU | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Selenium; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Selenium | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Selenium; Assigned to Arm(s): Selenium | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Multivitamins (B,C,E); Type: EXPERIMENTAL; Interventions: Dietary Supplement: Multivitamin supplements B,C and E | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Multivitamin supplements B,C and E | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamin supplements B,C and E; Assigned to Arm(s): Multivitamins (B,C,E), Placebo
D: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Multivitamins; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Multivitamins | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamins; Assigned to Arm(s): Multivitamins | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Nutrition, Immunology and Epidemiology of Tuberculosis
Brief Summary: The purpose of this study is to determine the efficacy of micronutrient supplementation among patients with active tuberculosis, half of who are co-infected with HIV-1


Options:
A: Intervention Type: DRUG; Name: Cholecalciferol; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Migliol Placebo Oil; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: L-arginine, Drug: Vitamin D | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin D, Drug: Placebo L-arginine | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: L-arginine, Drug: Placebo Vitamin D | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo L-arginine, Drug: Placebo Vitamin D | Intervention Type: DRUG; Name: L-arginine; Assigned to Arm(s): 1, 3 | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 1, 2 | Intervention Type: DRUG; Name: Placebo L-arginine; Assigned to Arm(s): 2, 4 | Intervention Type: DRUG; Name: Placebo Vitamin D; Assigned to Arm(s): 3, 4
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Multivitamins; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Multivitamins | Intervention Type: DIETARY_SUPPLEMENT; Name: Multivitamins; Assigned to Arm(s): Multivitamins | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Study drug containing zinc alone; Type: EXPERIMENTAL; Interventions: Drug: Zinc | Arm Label: Study drug Micronutrient without zinc; Type: EXPERIMENTAL; Interventions: Drug: Micronutrient without zinc | Arm Label: Study drug Micronutrient with zinc; Type: EXPERIMENTAL; Interventions: Drug: Micronutrient with zinc | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Zinc; Assigned to Arm(s): Study drug containing zinc alone | Intervention Type: DRUG; Name: Micronutrient without zinc; Assigned to Arm(s): Study drug Micronutrient without zinc | Intervention Type: DRUG; Name: Micronutrient with zinc; Assigned to Arm(s): Study drug Micronutrient with zinc | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trial of Vitamins Among Children of HIV-infected Women
Brief Summary: The purpose of this study is to examine the effects of multivitamin (B, C, E) supplementation on reducing the risk of morbidity and mortality outcomes among children born to HIV positive mothers, compared to placebo supplementation.


Options:
A: Arm Label: Multivitamins; Type: EXPERIMENTAL; Interventions: Drug: Multivitamins - vitamins B complex, C and E | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Multivitamins - vitamins B complex, C and E; Assigned to Arm(s): Multivitamins | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Placebo; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Cholecalciferol, Dietary Supplement: Calcium, Dietary Supplement: Calcium and cholecalciferol, Drug: Placebo | Arm Label: Calcium; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Cholecalciferol, Dietary Supplement: Calcium, Dietary Supplement: Calcium and cholecalciferol, Drug: Placebo | Arm Label: Cholecalciferol; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Cholecalciferol, Dietary Supplement: Calcium, Dietary Supplement: Calcium and cholecalciferol, Drug: Placebo | Arm Label: Calcium and cholecalciferol; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Cholecalciferol, Dietary Supplement: Calcium, Dietary Supplement: Calcium and cholecalciferol, Drug: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol; Assigned to Arm(s): Calcium, Calcium and cholecalciferol, Cholecalciferol, Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Calcium; Assigned to Arm(s): Calcium, Calcium and cholecalciferol, Cholecalciferol, Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Calcium and cholecalciferol; Assigned to Arm(s): Calcium, Calcium and cholecalciferol, Cholecalciferol, Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Calcium, Calcium and cholecalciferol, Cholecalciferol, Placebo
C: Intervention Type: DIETARY_SUPPLEMENT; Name: multiple micronutrients; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): 3

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Trial of Vitamins Among Children of HIV-infected Women
Brief Summary: The purpose of this study is to examine the effects of multivitamin (B, C, E) supplementation on reducing the risk of morbidity and mortality outcomes among children born to HIV positive mothers, compared to placebo supplementation.


Options:
A: Arm Label: Multivitamins; Type: EXPERIMENTAL; Interventions: Drug: Multivitamins | Arm Label: Multivitamins + Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc, Drug: Multivitamins | Arm Label: Zinc; Type: EXPERIMENTAL; Interventions: Drug: Zinc | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Zinc; Assigned to Arm(s): Multivitamins + Zinc, Zinc | Intervention Type: DRUG; Name: Multivitamins; Assigned to Arm(s): Multivitamins, Multivitamins + Zinc | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Zinc syrup; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Liquid zinc syrup | Arm Label: Zinc tablet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Zinc tablet | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Liquid placebo supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: Liquid zinc syrup; Assigned to Arm(s): Zinc syrup | Intervention Type: DIETARY_SUPPLEMENT; Name: Zinc tablet; Assigned to Arm(s): Zinc tablet | Intervention Type: DIETARY_SUPPLEMENT; Name: Liquid placebo supplement; Assigned to Arm(s): Placebo
C: Arm Label: Multivitamins; Type: EXPERIMENTAL; Interventions: Drug: Multivitamins - vitamins B complex, C and E | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Multivitamins - vitamins B complex, C and E; Assigned to Arm(s): Multivitamins | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Intervention Type: DRUG; Name: Zinc; Assigned to Arm(s): N/A

Answer: C